Hauptseite > Publikationsdatenbank > Use of PET Imaging in Neuro-Oncological Surgery |
Review/Journal Article | FZJ-2021-02030 |
; ; ;
2021
MDPI
Basel
This record in other databases:
Please use a persistent id in citations: http://hdl.handle.net/2128/27732 doi:10.3390/cancers13092093
Abstract: This review provides an overview of current applications and perspectives of PET imaging in neuro-oncological surgery. The past and future of PET imaging in the management of patients with glioma and brain metastases are elucidated with an emphasis on amino acid tracers, such as O-(2-[18F]fluoroethyl)-L-tyrosine (18F-FET). The thematic scope includes surgical resection planning, prognostication, non-invasive prediction of molecular tumor characteristics, depiction of intratumoral heterogeneity, response assessment, differentiation between tumor progression and treatment-related changes, and emerging new tracers. Furthermore, the role of PET using specific somatostatin receptor ligands for the management of patients with meningioma is discussed. Further advances in neuro-oncological imaging can be expected from promising new techniques, such as hybrid PET/MR scanners and the implementation of artificial intelligence methods, such as radiomics.
![]() |
The record appears in these collections: |